glp 1 and antipsychotics GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA TrimRX | GLP-1 vs GIP:

Theres also limited data on who may be at higher risk for negative side effects

Weng, S.-W

Natural Eczema Relief - Greenford Eczema Support is a powerful and natural skin supplement with actual potent dosages of vitamins, minerals, amino acids, and probiotics that effectively treat various skin conditions, including eczema, stubborn acne, psoriasis & rosacea

Semaglutide helps reduce calorie intake while L-Carnitine supports increased fat burning, helping you lose weight more efficiently while maintaining energy and muscle mass

Case 1 Male patient died while receiving semaglutide report invalidated because call-center contractors claimed patient identifier was missing (FDA found it in source documents) Case 2 Consumer taking liraglutide suffered a disabling stroke report cancelled because the consumer said it was unrelated to the drug Case 3 Patient taking semaglutide became depressed and committed suicide no follow-up attempts documented, still not submitted to FDA as of March 2026 Case 4 Consumer reported suicidal ideation on semaglutide in December 2024 not reviewed until February 2025, only after FDA inspectors flagged it Case 5 FDA found Novo Nordisk's written procedures allowed adverse events to be rejected based on causality assessments contradicting federal reporting requirements A Second Front: Vision Loss Claims Beyond the GI injury cases, a second GLP-1 MDL was created in December 2025 for vision loss claims